Search Results - "HELLER, P. G."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Anagrelide platelet‐lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms by Espasandin, Y. R., Glembotsky, A. C., Grodzielski, M., Lev, P. R., Goette, N. P., Molinas, F. C., Marta, R. F., Heller, P. G.

    Published in Journal of thrombosis and haemostasis (01-04-2015)
    “…Summary Background and Objectives Anagrelide represents a treatment option for essential thrombocythemia patients. It lowers platelet counts through inhibition…”
    Get full text
    Journal Article
  5. 5

    International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country by GLEMBOTSKY, A. C., MARTA, R. F., PECCI, A., DE ROCCO, D., GNAN, C., ESPASANDIN, Y. R., GOETTE, N. P., NEGRO, F., NORIS, P., SAVOIA, A., BALDUINI, C. L., MOLINAS, F. C., HELLER, P. G.

    Published in Journal of thrombosis and haemostasis (01-08-2012)
    “…Background:  Inherited thrombocytopenias (ITs) are heterogeneous genetic disorders that frequently represent a diagnostic challenge. The requirement of highly…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria by Heller, P G, Grinberg, A R, Lencioni, M, Molina, M M, Roncoroni, A J

    Published in Chest (01-08-1992)
    “…Pulmonary arterial hypertension (PAH) and cor pulmonale were found in a patient with paroxysmal nocturnal hemoglobinuria (PNH). Autopsy revealed widespread…”
    Get more information
    Journal Article
  8. 8

    Monocyte IL-2Rα expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms by Goette, N.P., Lev, P.R., Heller, P.G., Kornblihtt, L.I., Korin, L., Molinas, F.C., Marta, R.F.

    Published in Cytokine (Philadelphia, Pa.) (01-07-2010)
    “…The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (ET). Monocyte activation has been associated…”
    Get full text
    Journal Article
  9. 9

    Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis by Lev, P. R., Goette, N. P., Glembotsky, A. C., Laguens, R. P., Meckert, P. M. Cabeza, Salim, J. P., Heller, P. G., Pozner, R. G., Marta, R. F., Molinas, F. C.

    Published in Platelets (Edinburgh) (01-01-2011)
    “…The aim of this study was to evaluate cell maturation and the platelet production capacity of the megakaryoblastic DAMI cell line, to characterize…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia by Noris, Patrizia, Schlegel, Nicole, Klersy, Catherine, Heller, Paula G, Civaschi, Elisa, Pujol-Moix, Nuria, Fabris, Fabrizio, Favier, Remi, Gresele, Paolo, Latger-Cannard, Véronique, Cuker, Adam, Nurden, Paquita, Greinacher, Andreas, Cattaneo, Marco, De Candia, Erica, Pecci, Alessandro, Hurtaud-Roux, Marie-Françoise, Glembotsky, Ana C, Muñiz-Diaz, Eduardo, Randi, Maria Luigia, Trillot, Nathalie, Bury, Loredana, Lecompte, Thomas, Marconi, Caterina, Savoia, Anna, Balduini, Carlo L, Bayart, Sophie, Bauters, Anne, Benabdallah-Guedira, Schéhérazade, Boehlen, Françoise, Borg, Jeanne-Yvonne, Bottega, Roberta, Bussel, James, De Rocco, Daniela, de Maistre, Emmanuel, Faleschini, Michela, Falcinelli, Emanuela, Ferrari, Silvia, Ferster, Alina, Fierro, Tiziana, Fleury, Dominique, Fontana, Pierre, James, Chloé, Lanza, Francois, Le Cam Duchez, Véronique, Loffredo, Giuseppe, Magini, Pamela, Martin-Coignard, Dominique, Menard, Fanny, Mercier, Sandra, Mezzasoma, Annamaria, Minuz, Pietro, Nichele, Ilaria, Notarangelo, Lucia D, Pippucci, Tommaso, Podda, Gian Marco, Pouymayou, Catherine, Rigouzzo, Agnes, Royer, Bruno, Sie, Pierre, Siguret, Virginie, Trichet, Catherine, Tucci, Alessandra, Saposnik, Béatrice, Veneri, Dino

    Published in Haematologica (Roma) (01-08-2014)
    “…Pregnancy in women with inherited thrombocytopenias is a major matter of concern as both the mothers and the newborns are potentially at risk of bleeding…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    A Deep Dive into the Pathology of Gray Platelet Syndrome: New Insights on Immune Dysregulation by Glembotsky, Ana C, De Luca, Geraldine, Heller, Paula G

    Published in Journal of blood medicine (01-01-2021)
    “…The gray platelet syndrome (GPS) is a rare platelet disorder, characterized by impaired alpha-granule biogenesis in megakaryocytes and platelets due to NBEAL2…”
    Get full text
    Journal Article
  15. 15

    Monocyte IL-2Ralpha expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms by Goette, N P, Lev, P R, Heller, P G, Kornblihtt, L I, Korin, L, Molinas, F C, Marta, R F

    Published in Cytokine (Philadelphia, Pa.) (01-07-2010)
    “…The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (ET). Monocyte activation has been associated…”
    Get full text
    Journal Article
  16. 16

    Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation by Heller, Paula G., Glembotsky, Ana C., Gandhi, Manish J., Cummings, Carrie L., Pirola, Carlos J., Marta, Rosana F., Kornblihtt, Laura I., Drachman, Jonathan G., Molinas, Felisa C.

    Published in Blood (15-06-2005)
    “…Germ-line heterozygous mutations in the hematopoietic transcription factor AML1 (RUNX1) have been identified in patients with familial platelet disorder with…”
    Get full text
    Journal Article
  17. 17

    Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement by Kornblihtt, Laura I, Cocorullo, Silvia, Miranda, Carlos, Lylyk, Pedro, Heller, Paula G, Molinas, Felisa C

    Published in Stroke (1970) (01-08-2005)
    “…Essential thrombocythemia (ET) is a chronic myeloproliferative disorder with increased frequency of thrombotic events, including transient ischemic attacks…”
    Get full text
    Journal Article
  18. 18

    The clinical course of patients with septic abortion admitted to an intensive care unit by FINKIELMAN, Javier Daniel, DE FEO, Fabian Dario, HELLER, Paula Graciela, AFESSA, Bekele

    Published in Intensive care medicine (01-06-2004)
    “…The purpose of this study was to describe the clinical course, complications, and outcome of patients with septic abortion admitted to the intensive care unit…”
    Get full text
    Journal Article
  19. 19

    Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation by Grinberg, A R, Heller, P G, Correa, G, Sarano, J F, Molinas, F C, Nicastro, M A, Alvarez, C L

    Published in Medicina (Buenos Aires) (1999)
    “…Antiphospholipid syndrome is characterized by recurrent fetal loss, arterial and venous thromboses, thrombocytopenia and circulating antiphospholipid…”
    Get more information
    Journal Article
  20. 20

    PDGF‐A, PDGF‐B, TGFβ, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide by Lev, Paola R., Salim, Juan P., Kornblihtt, Laura I., Pirola, Carlos J., Marta, Rosana F., Heller, Paula G., Molinas, Felisa C.

    Published in American journal of hematology (01-02-2005)
    “…Plasmatic levels of PDGF‐AB, TGFβ1, and bFGF are increased in patients with essential thrombocythemia (ET) while intraplatelet levels are low for PDGF, normal…”
    Get full text
    Journal Article